
Anne Marie Falk
Examiner (ID: 427)
| Most Active Art Unit | 1632 |
| Art Unit(s) | 1632 |
| Total Applications | 685 |
| Issued Applications | 242 |
| Pending Applications | 153 |
| Abandoned Applications | 292 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7113444
[patent_doc_number] => 20050210536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Modulation of brain pathways and function'
[patent_app_type] => utility
[patent_app_number] => 11/005919
[patent_app_country] => US
[patent_app_date] => 2004-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12974
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0210/20050210536.pdf
[firstpage_image] =>[orig_patent_app_number] => 11005919
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/005919 | Modulation of brain pathways and function | Dec 5, 2004 | Abandoned |
Array
(
[id] => 5479661
[patent_doc_number] => 20090202618
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'Dna vaccines encoding hsp60 peptide fragments for treating autoimmune diseases'
[patent_app_type] => utility
[patent_app_number] => 10/580176
[patent_app_country] => US
[patent_app_date] => 2004-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 13950
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20090202618.pdf
[firstpage_image] =>[orig_patent_app_number] => 10580176
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/580176 | Dna vaccines encoding hsp60 peptide fragments for treating autoimmune diseases | Nov 23, 2004 | Abandoned |
Array
(
[id] => 6918140
[patent_doc_number] => 20050095701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-05
[patent_title] => 'PNS cell lines and methods of use therefor'
[patent_app_type] => utility
[patent_app_number] => 10/985784
[patent_app_country] => US
[patent_app_date] => 2004-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 13737
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0095/20050095701.pdf
[firstpage_image] =>[orig_patent_app_number] => 10985784
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/985784 | PNS cell lines and methods of use therefor | Nov 8, 2004 | Abandoned |
Array
(
[id] => 5867400
[patent_doc_number] => 20060101532
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-11
[patent_title] => 'Methods for the identification of compounds for the treatment of Alzheimer\'s disease'
[patent_app_type] => utility
[patent_app_number] => 10/983422
[patent_app_country] => US
[patent_app_date] => 2004-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 12654
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0101/20060101532.pdf
[firstpage_image] =>[orig_patent_app_number] => 10983422
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/983422 | Methods for the identification of compounds for the treatment of Alzheimer's disease | Nov 7, 2004 | Abandoned |
Array
(
[id] => 7047279
[patent_doc_number] => 20050251874
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-10
[patent_title] => 'Mice lacking alpha 1G showing enhanced novelty-seeking and alcohol preference and therapeutic methods for mood disorders by modulating alpha 1G T-type calcium channels'
[patent_app_type] => utility
[patent_app_number] => 10/971976
[patent_app_country] => US
[patent_app_date] => 2004-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 6533
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0251/20050251874.pdf
[firstpage_image] =>[orig_patent_app_number] => 10971976
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/971976 | Mice lacking alpha 1G showing enhanced novelty-seeking and alcohol preference and therapeutic methods for mood disorders by modulating alpha 1G T-type calcium channels | Oct 21, 2004 | Abandoned |
Array
(
[id] => 6938546
[patent_doc_number] => 20050112109
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Discovery, localization, harvest, and propagation of an FGF2 and BDNF-responsive population of neural and neuronal progenitor cells in the adult human forebrain'
[patent_app_type] => utility
[patent_app_number] => 10/969896
[patent_app_country] => US
[patent_app_date] => 2004-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12403
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20050112109.pdf
[firstpage_image] =>[orig_patent_app_number] => 10969896
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/969896 | Discovery, localization, harvest, and propagation of an FGF2 and BDNF-responsive population of neural and neuronal progenitor cells in the adult human forebrain | Oct 20, 2004 | Abandoned |
Array
(
[id] => 4841878
[patent_doc_number] => 20080282364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-13
[patent_title] => 'Phosphodiesterase 9 Inhibition as Treatment for Obesity-Related Conditions'
[patent_app_type] => utility
[patent_app_number] => 10/577700
[patent_app_country] => US
[patent_app_date] => 2004-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 17050
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0282/20080282364.pdf
[firstpage_image] =>[orig_patent_app_number] => 10577700
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/577700 | Phosphodiesterase 9 Inhibition as Treatment for Obesity-Related Conditions | Oct 17, 2004 | Abandoned |
Array
(
[id] => 7050790
[patent_doc_number] => 20050186677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-25
[patent_title] => 'Novel mutated mammalian cells and animals'
[patent_app_type] => utility
[patent_app_number] => 10/964549
[patent_app_country] => US
[patent_app_date] => 2004-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 5060
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20050186677.pdf
[firstpage_image] =>[orig_patent_app_number] => 10964549
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/964549 | Novel mutated mammalian cells and animals | Oct 12, 2004 | Abandoned |
Array
(
[id] => 5351922
[patent_doc_number] => 20090007283
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-01
[patent_title] => 'Transgenic Rodents Selectively Expressing Human B1 Bradykinin Receptor Protein'
[patent_app_type] => utility
[patent_app_number] => 10/573926
[patent_app_country] => US
[patent_app_date] => 2004-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13187
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0007/20090007283.pdf
[firstpage_image] =>[orig_patent_app_number] => 10573926
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/573926 | Transgenic Rodents Selectively Expressing Human B1 Bradykinin Receptor Protein | Oct 3, 2004 | Abandoned |
Array
(
[id] => 9112889
[patent_doc_number] => 08569058
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-29
[patent_title] => 'Nerve regeneration promoters'
[patent_app_type] => utility
[patent_app_number] => 10/574479
[patent_app_country] => US
[patent_app_date] => 2004-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 14131
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10574479
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/574479 | Nerve regeneration promoters | Sep 30, 2004 | Issued |
Array
(
[id] => 7235270
[patent_doc_number] => 20050262578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-24
[patent_title] => 'Non-human animal models of atherosclerosis and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/956790
[patent_app_country] => US
[patent_app_date] => 2004-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 19304
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0262/20050262578.pdf
[firstpage_image] =>[orig_patent_app_number] => 10956790
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/956790 | Non-human animal models of atherosclerosis and methods of use thereof | Sep 30, 2004 | Abandoned |
Array
(
[id] => 6996227
[patent_doc_number] => 20050136005
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-23
[patent_title] => 'Methods for modulation of cholesterol transport'
[patent_app_type] => utility
[patent_app_number] => 10/933037
[patent_app_country] => US
[patent_app_date] => 2004-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10292
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20050136005.pdf
[firstpage_image] =>[orig_patent_app_number] => 10933037
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/933037 | Methods for modulation of cholesterol transport | Sep 1, 2004 | Abandoned |
Array
(
[id] => 4771375
[patent_doc_number] => 20080057033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-06
[patent_title] => 'Neural Stem Cells and Methods of Generating and Utilizing Same'
[patent_app_type] => utility
[patent_app_number] => 10/559929
[patent_app_country] => US
[patent_app_date] => 2004-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10096
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0057/20080057033.pdf
[firstpage_image] =>[orig_patent_app_number] => 10559929
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/559929 | Neural Stem Cells and Methods of Generating and Utilizing Same | Jun 8, 2004 | Abandoned |
Array
(
[id] => 7597636
[patent_doc_number] => 07618941
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-11-17
[patent_title] => 'Treating degenerative joint disorders with tribonectins'
[patent_app_type] => utility
[patent_app_number] => 10/858595
[patent_app_country] => US
[patent_app_date] => 2004-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9656
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/618/07618941.pdf
[firstpage_image] =>[orig_patent_app_number] => 10858595
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/858595 | Treating degenerative joint disorders with tribonectins | May 31, 2004 | Issued |
Array
(
[id] => 7199594
[patent_doc_number] => 20040205833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-14
[patent_title] => 'Human disease modeling using somatic gene transfer'
[patent_app_type] => new
[patent_app_number] => 10/477167
[patent_app_country] => US
[patent_app_date] => 2004-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13882
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0205/20040205833.pdf
[firstpage_image] =>[orig_patent_app_number] => 10477167
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/477167 | Human disease modeling using somatic gene transfer | May 31, 2004 | Abandoned |
Array
(
[id] => 7247302
[patent_doc_number] => 20050081257
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-14
[patent_title] => 'Method of producing non-human mammals'
[patent_app_type] => utility
[patent_app_number] => 10/850344
[patent_app_country] => US
[patent_app_date] => 2004-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7278
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20050081257.pdf
[firstpage_image] =>[orig_patent_app_number] => 10850344
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/850344 | Method of producing non-human mammals | May 18, 2004 | Abandoned |
Array
(
[id] => 7199623
[patent_doc_number] => 20040205838
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-14
[patent_title] => 'Use of Flp recombinase in mice'
[patent_app_type] => new
[patent_app_number] => 10/846700
[patent_app_country] => US
[patent_app_date] => 2004-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12889
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0205/20040205838.pdf
[firstpage_image] =>[orig_patent_app_number] => 10846700
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/846700 | Use of Flp recombinase in mice | May 16, 2004 | Abandoned |
Array
(
[id] => 7060546
[patent_doc_number] => 20050002906
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'Gene therapy using replication competent targeted adenoviral vectors'
[patent_app_type] => utility
[patent_app_number] => 10/845489
[patent_app_country] => US
[patent_app_date] => 2004-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6387
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20050002906.pdf
[firstpage_image] =>[orig_patent_app_number] => 10845489
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/845489 | Gene therapy using replication competent targeted adenoviral vectors | May 11, 2004 | Abandoned |
Array
(
[id] => 7077713
[patent_doc_number] => 20050149994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-07
[patent_title] => 'Rapidly maturing fluorescent proteins and methods for using the same'
[patent_app_type] => utility
[patent_app_number] => 10/844064
[patent_app_country] => US
[patent_app_date] => 2004-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 21270
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0149/20050149994.pdf
[firstpage_image] =>[orig_patent_app_number] => 10844064
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/844064 | Rapidly maturing fluorescent proteins and methods for using the same | May 10, 2004 | Issued |
Array
(
[id] => 7428682
[patent_doc_number] => 20040209369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-21
[patent_title] => 'Controlling gene expression in living cells'
[patent_app_type] => new
[patent_app_number] => 10/838951
[patent_app_country] => US
[patent_app_date] => 2004-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5491
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20040209369.pdf
[firstpage_image] =>[orig_patent_app_number] => 10838951
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/838951 | Controlling gene expression in living cells | May 2, 2004 | Abandoned |